Sequential versus concurrent adjuvant chemo-endocrine therapy for HR+ early breast cancer: a systematic review and Bayesian network meta-analysis
Tianfu Li(Jinling Institute of Technology), Ying‐Hung Lin(Fu Jen Catholic University), Yawei Shi(The First Affiliated Hospital, Sun Yat-sen University), Nan Shao(The First People's Hospital of Changzhou), Zhen Shan(Shenyang Medical College), Shou‐Ching Tang(University of Mississippi Medical Center), Yu Liang(Northeast Agricultural University), Xiaying Kuang(Sun Yat-sen University)
Cited by 4
Related Papers
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
|Nature Communications|2021|358
ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
|Clinical Cancer Research|2020|248
Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
|Cancer Cell International|2020|136
An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells
|Journal of the American College of Cardiology|2015|126
Activation of NLRP3 Inflammasome Promotes Foam Cell Formation in Vascular Smooth Muscle Cells and Atherogenesis Via HMGB1
|Journal of the American Heart Association|2018|88